BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30818393)

  • 1. Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study.
    Kornej J; Zeynalova S; Thiery J; Burkhardt R; Baber R; Engel C; Hagendorff A; Loeffler M; Husser D
    PLoS One; 2019; 14(2):e0212627. PubMed ID: 30818393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.
    Schumacher K; Büttner P; Dagres N; Sommer P; Dinov B; Hindricks G; Bollmann A; Kornej J
    PLoS One; 2018; 13(11):e0206933. PubMed ID: 30395598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
    Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic PR prolongation and atrial fibrillation risk: a meta-analysis of prospective cohort studies.
    Cheng M; Lu X; Huang J; Zhang S; Gu D
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):36-41. PubMed ID: 25199533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study.
    Nielsen JB; Pietersen A; Graff C; Lind B; Struijk JJ; Olesen MS; Haunsø S; Gerds TA; Ellinor PT; Køber L; Svendsen JH; Holst AG
    Heart Rhythm; 2013 Sep; 10(9):1249-56. PubMed ID: 23608590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.
    Schumacher K; Dagres N; Hindricks G; Husser D; Bollmann A; Kornej J
    Clin Res Cardiol; 2017 Oct; 106(10):767-775. PubMed ID: 28382425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study.
    Tuluce K; Yakar Tuluce S; Kahya Eren N; Kocabas U; Akyildiz Akcay F; Gunduz R; Akyildiz ZI; Ergene O
    Echocardiography; 2016 Mar; 33(3):379-85. PubMed ID: 26493159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation study.
    Gajendragadkar PR; Von Ende A; Ibrahim M; Valdes-Marquez E; Camm CF; Murgia F; Stiby A; Casadei B; Hopewell JC
    PLoS Med; 2021 May; 18(5):e1003572. PubMed ID: 33983917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.
    Soeki T; Matsuura T; Tobiume T; Bando S; Matsumoto K; Nagano H; Uematsu E; Kusunose K; Ise T; Yamaguchi K; Yagi S; Fukuda D; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
    Circ J; 2018 Aug; 82(9):2253-2258. PubMed ID: 29848884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers, echocardiographic parameters, and incident subclinical atrial fibrillation in patients with diabetes and hypertension.
    Philippsen TJ; Christensen LS; Nybo M; Hansen MS; Dahl JS; Brandes A
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):35-42. PubMed ID: 34739729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation.
    Sieweke JT; Pfeffer TJ; Biber S; Chatterjee S; Weissenborn K; Grosse GM; Hagemus J; Derda AA; Berliner D; Lichtinghagen R; Hilfiker-Kleiner D; Bauersachs J; Bär C; Thum T; Bavendiek U
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study.
    Kornej J; Friedrich K; Schroeter ML; Witte AV; Polyakova M; Villringer A; Löffler M; Zeynalova S
    PLoS One; 2022; 17(6):e0269815. PubMed ID: 35704643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMA, subclinical changes and atrial fibrillation in the general population.
    Ramuschkat M; Appelbaum S; Atzler D; Zeller T; Bauer C; Ojeda FM; Sinning CR; Hoffmann B; Lackner KJ; Böger RH; Wild PS; Münzel T; Blankenberg S; Schwedhelm E; Schnabel RB;
    Int J Cardiol; 2016 Jan; 203():640-6. PubMed ID: 26580348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.
    Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Orenes-Piñero E; Caballero L; Jara-Rubio R; Arribas JM; García-Alberola A; Valdés M; Lip GY; Marín F
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):733-8. PubMed ID: 24163361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
    Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.